Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • Bitcoin USD

    61,012.80
    -1,777.48 (-2.83%)
     
  • CMC Crypto 200

    1,261.74
    -96.27 (-7.09%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • Dow

    39,512.84
    +125.08 (+0.32%)
     
  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     
  • Gold

    2,366.90
    +26.60 (+1.14%)
     
  • Crude Oil

    78.20
    -1.06 (-1.34%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

4 T. Rowe Price Mutual Funds for a Healthy Portfolio

Headquartered in Baltimore, MD, T. Rowe Price is a renowned publicly owned investment management firm. The company was founded in 1937 by Thomas Rowe Price, Jr. It managed assets worth $1.1trillion as of Apr 30, 2018 and prides itself in having more than 6,000 associates, including 971 investment professionals all over the world.

The company has around 16 offices globally and operates in four continents. It offers a full range of investment planning and guidance tools. The other offerings include mutual funds, sub-advisory services, retirement plans and separate account management for individual clients.

Below we share with you four top-ranked T. Rowe Price mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of T. Rowe Price funds.

T. Rowe Price Small-Cap Value Fund PRSVX aims for long-term capital growth. The fund invests a bulk of its net assets in companies that have a market capitalization in or below the range of companies on the Russell 2000 Index. PRSVX has three-year annualized returns of 10.3%.

ADVERTISEMENT

J. David Wagner is the fund manager of PRSVX since 2014.

T. Rowe Price Health Sciences Fund PRHSX aims for long-term capital growth. The fund invests mostly in common stocks of companies that are engaged in research, development, production or distribution of products or services in the health care sector. The non-diversified fund mostly invests in mid- or large-capitalization companies. PRHSX has three-year annualized returns of 10.8%.

PRHSX has an expense ratio of 0.77% compared with the category average of 1.22%.

T. Rowe Price Tax-Efficient Equity Fund PREFX seeks to increase after-tax growth of capital through investments mostly in common stocks. The fund aims to buy and hold stocks of lucratively valued, high-quality growth companies for the long term. PREFX has three-year annualized returns of 15.9%.

As of March 2019, PREFX held 368 issues with 3.25% of its assets invested in Amazon.com Inc.

VY T. Rowe Price Diversified Mid Cap Growth I Fund IAXIX seeks growth of capital for the long run. IAXIX invests the bulk of its assets in companies, which fall within the range of the Russell Midcap Growth Index or the S&P MidCap 400 Index. VY T. Rowe Price Diversified Mid Cap Growth I Fund has three-year annualized returns of 14.7%.

IAXIX has an expense ratio of 0.77% compared with the category average of 1.18%.

To view the Zacks Rank and past performance of all T. Rowe Price mutual funds, investors can click here to see the complete list of T. Rowe Price funds.

Want key mutual fund info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Get Your Free (PRHSX): Fund Analysis Report
 
Get Your Free (PRSVX): Fund Analysis Report
 
Get Your Free (PREFX): Fund Analysis Report
 
Get Your Free (IAXIX): Fund Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research